Abstract
Background
For the effective management of hypertension, drug adherence and life style modification are important. We investigated the effects of mobile phone text‐message reminders on compliance and life style modification in patients with hypertension.
Methods
The study was performed at family medicine outpatient clinics at 15 hospitals in South Korea from July 2008 to June 2010. Study subjects included 1,449 patients who were all prescribed candesartan cilexetil. Patients were randomly divided into two groups‐ mobile phone text‐message reminder group and control group. In the reminder group, contents of text messages were recommendations for antihypertensive adherence, exercise, low salt diet, and reduction of weight and alcohol. In the control group, the date of next visit was sent at 10 week. Mobile phone text-messages were sent at 2, 4, 6, 8 and 10 weeks by the coordinating center. Thereafter, they were followed up for 12 weeks. Chi-square test was performed to compare compliance and performance indexes of the two groups.
Results
The reminder group had 719 (49.6%) patients vs. 730 (50.4%) patients in the control group. Attendance rate were 92.8% for the reminder group and 94.7% for the control group (P=0.14). 94.7% of the reminder group and 94.0% of the control group took their medication regularly (P=0.59). The target blood pressure was attained in 75.8% of the reminder group and 75.4% of the control group (P=0.87). Similarly, rates of weight loss, decreased alcohol use, increased physical activity and a low salt diet showed no significant differences between the two groups.
References
1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903–13.
2. WHO. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. World Health Organization(WHO). 2007. http://whqlibdoc.who.int/pub-lications/2007/9789241547178_eng.pdf?ua=1.
3. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Available from:. https://knhanes.cdc.go.kr/knhanes/index.do.
4. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010; 303(20):2043–50.
5. WHO. Adherence to longterm therapies: evidence to action. World Health Organization (WHO). 2003. http://whqlibdoc.-who.int/publications/2003/9241545992.pdf.
6. Grant RW, Singer DE, Meigs JB. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005; 27(6):773–81.
7. Cramer JA, Benedict Á, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008; 62(1):76–87.
8. Park JH. Antihypertensive drug medication adherence of national health insurance beneficiaries and its affecting factors in Korea [dissertation]. Seoul: Seoul National University;2006. Korean.
9. Choi NH, Kim HK, Lee HR, Kim KS. A Study of the Factors influencing the Compliance of Hypertensive Patients to Therapy -Centered on the Registered Patients of Hypertension in a Rural Clinic–. Family physician. 1991; 12(10):1–12.
10. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and Medical treatment outcomes: a metaanalysis. Med Care. 2002; 40(9):794–811.
11. Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare Part D. J Am Pharm Assoc. 2006; 46(6):683–91.
12. Ministry of Health and Welfare. National Health Plan 2020. http://www.mindbank.info/item/4070.
13. Chen Z, Fang L, Chen L, Dai H. Comparison of an SMS text messaging and phone reminder to improve attendance at a health promotion center: a randomized controlled trial. Journal of Zhejiang University SCIENCE B. 2008; 9(1):34–8.
14. Korean Statistical Information Center. The number of mobile phone subscriptions. http://kosis.kr/statisticsList/statisticsL-ist_03List.jsp?vwcd=MT_RTITLE&parmTabId=M_03_01#Su. bCont.
15. Viswanathan H, Lambert BL. An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension. Research in Social and Administrative Pharmacy. 2005; 1(1):21–39.
16. Gohar F, Greenfield SM, Beevers DG, Lip GY, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complementary and Alternative Medicine. 2008; 8:4.
17. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003; 163(6):681–7.
18. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Circulation. 2003; 107:2993–4.
19. The Korean Society of Hypertension. 2004 Korean Hypertension Treatment Guidelines. The Korean Society of Hypertension;2005.
20. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and Reliability of Korean Version of International Physical Activity Questionnaire (IPAQ) Short Form. Korean J Fam Med. 2007; 28(7):532–41.
21. Kim HJ, Paik HY, Lee SY, Shim JE, Kim YS. Salt usage behaviors are related to urinary sodium excretion in normotensive Korean adults. Asia Pacific Journal of Clinical Nutrition. 2007; 16(1):122–7.
22. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011; 25(6):825–34.
23. Dick JJ, Nundy S, Solomon MC, Bishop KN, Chin MH, Peek ME. Feasibility and usability of a text message-based program for diabetes self-management in an urban African-American population. Journal of Diabetes Science and Technology. 2011; 5(5):1246–54.
24. Hussein WI, Hasan K, Jaradat AA. Effectiveness of mobile phone short message service on diabetes mellitus management; the SMS-DM study. Diabetes Res Clin Pract. 2011; 94(1):e24–6.
25. Márquez Contreras E, de la Figuera von Wichmann M, Gil Guillén V, Ylla-Catalá A, Figueras M, Balaña M, at al. Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to theirmobile phone (HTA-Alert). Aten Primaria. 2004; 34(8):399–405.
26. Park KA. The related factors on medication adherence in elderly patients with hypertension or diabetes mellitus [dissertation]. Daegu: Kyungpook National University;2010. Korean.
27. Kim HW, Lee YJ, Youn BB. A follow up study for drop-out of hypertensive patients registered in a community hospital. Family Physician. 1986; 7(1):1–11.
Table 1–1.
Variables | Text message reminder (n=719) | Control (n=730) | Pb |
---|---|---|---|
Sex | |||
Man | 309 (43.0) | 296 (40.4) | 0.350 |
Woman | 410 (57.0) | 434 (59.4) | |
Age, y | 59.7±10.7 | 58.7±10.3 | 0.100 |
<50 | 135 (18.8) | 127 (17.4) | 0.100 |
50–59 | 213 (29.6) | 256 (35.1) | |
60–69 | 241 (33.5) | 240 (32.9) | |
≥70 | 130 (18.1) | 107 (14.6) | |
Monthly income, million Korean Won | |||
<200 | 170 (25.8) | 141 (21.4) | 0.170 |
200–399 | 204 (30.9) | 219 (33.2) | |
≥400 | 286 (43.3) | 299 (45.4) | |
Education, y | |||
<12 12 | 188 (27.5) 263 (38.4) | 183 (26.2) 276 (39.5) | 0.850 |
>12 | 233 (34.1) | 239 (34.3) | |
Marital status | |||
Married | 585 (84.1) | 612 (86.2) | 0.260 |
Not married | 111 (15.9) | 98 (13.8) | |
Smoking | |||
None-smoker | 473 (66.4) | 463 (64.3) | 0.310 |
Ex-smoker | 145 (20.4) | 170 (23.6) | |
Smoker | 94 (13.2) | 87 (12.1) | |
Alcohol use | |||
None-drinker | 438 (62.5) | 454 (63.9) | 0.570 |
Drinker | 263 (37.5) | 256 (36.1) | |
Degree of physical activity | |||
Inactive | 280 (40.1) | 312 (43.8) | 0.240 |
Minimally active | 269 (38.5) | 270 (37.9) | |
Health enhancing (vigorous) | 149 (21.4) | 130 (18.3) | |
Body mass index, kg/m2 | 25.5±3.4 | 25.3±5.5 | 0.420 |
Blood pressure, mmHg | |||
<140 and <90 | 294 (42.9) | 305 (43.9) | 0.720 |
≥140 or ≥90 | 391 (57.1) | 390 (56.1) | |
Habit of salt intake | |||
Normal intake | 398 (55.7) | 405 (56.3) | 0.850 |
High intake | 316 (44.3) | 315 (43.7) |
Table 1–2.
Variables | Text message reminder (n=719) | Control (n=730) | Pb |
---|---|---|---|
Family history of disease | |||
Hypertension | 330 (47.7) | 326 (46.4) | 0.620 |
Diabetes mellitus | 150 (21.7) | 149 (21.2) | 0.840 |
Stroke | 128 (18.5) | 139 (19.8) | 0.540 |
Heart disease | 79 (11.4) | 90 (12.8) | 0.430 |
Comorbidity | 398 (58.2) | 385 (55.6) | 0.320 |
Diabetes mellitus | 155 (22.7) | 138 (20.0) | 0.220 |
Hyperlipidemia | 335 (49.2) | 323 (47.0) | 0.410 |
Heart disease | 14 (2.1) | 11 (1.6) | 0.530 |
Cerebrovascular disease | 13 (1.9) | 12 (1.7) | 0.820 |
History of having taken antihypertensive agents | |||
Yes | 480 (68.0) | 474 (65.5) | 0.300 |
No | 226 (32.0) | 250 (34.5) | |
Concurrently prescribed medication | 496 (72.3) | 499 (72.2) | 0.970 |
Antihypertensive agents taking with candesartan cilexetil | 264 (38.5) | 253 (36.7) | 0.470 |
Antidiabetic agents | 143 (20.9) | 127 (18.4) | 0.250 |
Serum lipid lowering agents | 338 (49.3) | 310 (44.9) | 0.100 |
Antiplatelet agents | 161 (23.5) | 177 (25.7) | 0.360 |
Other cardiovascular medications | 10 (1.5) | 5 (0.7) | 0.190 |
Table 2.
Variables | Text message reminder (n=719) | Control (n=730) | Pb |
---|---|---|---|
Attendance | |||
Yes | 605 (92.8) | 631 (94.7) | 0.140 |
No | 47 (7.2) | 35 (5.3) | |
Drug adherence | |||
≥80% | 612 (94.7) | 616 (94.0) | 0.590 |
<80% | 34 (5.3) | 39 (6.0) | |
Controlled blood pressurec | |||
Yes | 500 (75.8) | 508 (75.4) | 0.870 |
No | 160 (24.2) | 166 (24.6) | |
Weight lossd | |||
Yes | 40 (6.6) | 43 (6.9) | 0.800 |
No | 568 (93.4) | 576 (93.1) | |
Reduced alcohol usee | |||
Yes | 68 (11.1) | 68 (11.0) | 0.940 |
No | 542 (88.9) | 550 (89.0) | |
Increased regular exercisee | |||
Yes | 123 (18.8) | 117 (17.5) | 0.550 |
No | 531 (81.2) | 550 (82.5) | |
Reduced dietary sodium intakee | |||
Yes | 219 (33.4) | 205 (30.8) | 0.300 |
No | 430 (65.7) | 459 (68.9) |